Sulfonylureas: effects in vivo and in vitro.
D000262:Adenylyl Cyclases / Q000378:metabolism; D001786:Blood Glucose / Q000032:analysis; D001792:Blood Platelets / Q000187:drug effects; D002986:Clinical Trials as Topic; D046508:Culture Techniques; D000242:Cyclic AMP / Q000378:metabolism*; D003864:Depression, Chemical; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000401:mortality / Q000517:prevention & control*; D004035:Diet Therapy; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D007328:Insulin; D007515:Islets of Langerhans / Q000187:drug effects / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000201:enzymology; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism*; D010919:Placebos; D011446:Prospective Studies; D013453:Sulfonylurea Compounds / Q000494:pharmacology*; D014044:Tolbutamide / Q000494:pharmacology
D001786:Blood Glucose; D007328:Insulin; D010919:Placebos; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D000242:Cyclic AMP; D010744:Phosphoric Monoester Hydrolases; D000262:Adenylyl Cyclases